In the press

07.28.2026

Auxilium Health Is Now Aeris Biosciences

Derived from biomaterials engineered to architect the foundation the body heals on, rather than sit passively on it, Aeris reflects what our platform actually can be.

07.14.2026

Auxilium Health Closes Oversubscribed $3.4 Million Seed Round to Advance Its Aer™ Biomaterial Platform

Auxilium Health today announced the close of an oversubscribed $3.4 million seed round, a year after closing its pre-seed, to advance its Aer™ biomaterial platform toward FDA clearance and first-in-human studies.

12.09.2025

AUXILIUM AWARDED R&D FUNDING FROM POLYMER INDUSTRY CLUSTER

Akron Polymer Industry Cluster announced new innovation projects supporting regional polymer startups, including Auxilium’s infection-preventing biomaterial technology.

10.07.2025

OUR FOUNDER AND CEO, ISAIAH KAISER, HIGHLIGHTED BY HIS ALMA MATER

University of Akron features alumnus Isaiah Kaiser and Auxilium Health’s early progress developing innovative biomaterials to prevent infection and improve wound healing.

09.30.2025

BOUNCE SELECTS AUXILIUM AMONG INAUGURAL POLYMER ACCELERATOR COHORT

Bounce Innovation Hub launches its polymer-focused accelerator and selects Auxilium Health among the first cohort of startups advancing next-generation materials technologies.

04.11.2025

AUXILIUM CLOSES OVERSUBSCRIBED $1.5 MILLION PRE-SEED FINANCING ROUND

Auxilium Health raises $1.5 million in oversubscribed pre-seed funding to accelerate development and commercialization of its advanced infection-preventing biomaterials.

03.01.2025

AUXILIUM AWARDED NATIONAL SCIENCE FOUNDATION SBIR PHASE I

National Science Foundation awards Auxilium Health an SBIR Phase I grant supporting early development of its bio-based aerogel platform.

04.24.2024

THE OHIO DEPARTMENT OF DEVELOPMENT AWARDS AUXILIUM $200,000

The Ohio Third Frontier Commission awarded Auxilium Health a $200,000 Third Frontier Technology Validation and Start-up Fund grant to help patients suffering from chronic wounds.